| Prostatic Diseases |
NCT01317043: A Trial of Samarium 153 Followed by Salvage Prostatic Fossa 3D-CRT or IMRT Irradiation in High-Risk, Clinically Non-Metastatic Prostate Cancer After Radical Prostatectomy |
|
|
| Recruiting | 2 | 76 | US | Samarium/IMRT, Samarium ethylenediaminetetramethylenephosphonate | Sentara Norfolk General Hospital, RTOG | Non-metastatic Prostate Cancer, Post Radical Prostatectomy | | | | |
| Completed | 2 | 63 | RoW | Dendritic Cells DCVAC/PCa, Leuprolide acetate, Lupron, Goserelin Acetate, Zoladex | SOTIO a.s., Ascend Biopharmaceuticals Ltd | Basal Cell Carcinoma, Basal Cell Nevus Syndrome (BCNS) | 12/15 | 06/16 | | |
NCT00003915: Chemotherapy and Hormone Therapy in Treating Patients With Prostate Cancer |
|
|
| Active, not recruiting | 2 | 63 | US | bicalutamide, docetaxel, estramustine phosphate sodium, leuprolide acetate | University of Massachusetts, Worcester | Prostate Cancer | 02/18 | 02/18 | | |
NCT02040610: Hypofractionated Image Guided Proton Therapy for Low andIntermediate Risk Prostate Cancer |
|
|
| Recruiting | 2 | 235 | US | Hypofractionated Proton Therapy, Proton Therapy | Provision Center for Proton Therapy, Center for Biomedical Research, LLC | Prostate Cancer | 12/19 | 12/25 | | |
NCT01913106: HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer |
|
|
| Recruiting | 1/2 | 25 | US | HSV-tk +Valacyclovir in Combination with Brachytherapy, IND 13567 | The Methodist Hospital Research Institute | Prostatic Neoplasms | 12/18 | 12/28 | | |
